PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk

12:12 EDT 14 May 2019 | Nature Publishing

More From BioPortfolio on "PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk"